United States

Securities and Exchange Commission

Washington, D.C. 20549

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant

to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

Pursuant to § 240.13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.    )*

GoHealth, Inc.

(Name of Issuer)

Class A Common Stock, $0.0001 par value per share

(Title of Class of Securities)

38046W105

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

GoHealth, Inc. (the “Issuer”).

214 West Huron St., Chicago, Illinois, 60654.

Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

CCP III Cayman GP Ltd. (“CCP GP”);

Centerbridge Associates III, L.P. (“Centerbridge Associates”);

CCP III AIV VII Holdings, L.P. (“CCP III”);

CB Blizzard Co-Invest Holdings, L.P. (“CB Blizzard”);

Blizzard Aggregator, LLC (“Blizzard Aggregator”); and

Jeffrey Aronson.

The principal business address of the Reporting Persons is 375 Park Avenue, 11th Floor, New York, New York 10152.

CCP GP is organized under the laws of the Cayman Islands. Mr. Aronson is a citizen of the United States. Each of the other Reporting Persons is organized under the laws of the State of Delaware.

Class A Common Stock, $0.0001 par value per share (“Class A Common Stock”).

38046W105

Not applicable.

(a-c)

The ownership information presented below represents beneficial ownership of Class A Common Stock of the Issuer as of December 31, 2020 based upon 84,182,961 shares of Class A Common Stock outstanding as of November 6, 2020 as reported in the quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2020 and assumes the redemption of the LLC Interests held of record by Blizzard Aggregator as of the date hereof. The LLC Interests may be redeemed at any time for shares of Class A Common Stock on a one-to-one basis.

CCP III is the record holder of 23,129,333 shares of Class A Common Stock. CB Blizzard is the record holder of 17,553,628 shares of Class A Common Stock. Blizzard Aggregator is the record holder of 80,792,677 LLC Interests.

CCP GP is the general partner of Centerbridge Associates, which is the general partner of each of CCP III and CB Blizzard. As a result, each of CCP GP and Centerbridge Associates may be deemed to share beneficial ownership of the Class A Common Stock held by CCP III and CB Blizzard. CCP GP is also the sole manager of Blizzard Aggregator and may be deemed to share beneficial ownership of the LLC Interests held by Blizzard Aggregator. Mark T. Gallogly retired from Centerbridge Partners, L.P. effective December 7, 2020. Jeffrey H. Aronson is the sole director of CCP GP and, as a result, may be deemed to beneficially own the securities held by each of CCP III, CB Blizzard and Blizzard Aggregator. However, none of the foregoing should be construed in and of itself as an admission by Mr. Aronson or by any Reporting Person as to beneficial ownership of securities owned by another Reporting Person. In addition, Mr. Aronson expressly disclaims beneficial ownership of the shares of Class A Common Stock held by each of CCP III and CB Blizzard, as well as the LLC Interests held by Blizzard Aggregator, except to the extent of any proportionate pecuniary interest therein.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:    February 4, 2021

LIST OF EXHIBITS

Exhibit 99

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 4^th day of February, 2021.